Unique ID issued by UMIN | UMIN000028612 |
---|---|
Receipt number | R000032737 |
Scientific Title | The effect of protein supplementation at breakfast or supper for 12 weeks beyond habitual intakes on lean body mass and bone mineral density. |
Date of disclosure of the study information | 2017/08/10 |
Last modified on | 2019/02/12 19:13:41 |
The effect of protein supplementation at breakfast or supper for 12 weeks beyond habitual intakes on lean body mass and bone mineral density.
The effect of protein supplementation at breakfast or supper for 12 weeks beyond habitual intakes on lean body mass and bone mineral density.
The effect of protein supplementation at breakfast or supper for 12 weeks beyond habitual intakes on lean body mass and bone mineral density.
The effect of protein supplementation at breakfast or supper for 12 weeks beyond habitual intakes on lean body mass and bone mineral density.
Japan |
sarcopenia, osteoporosis
Not applicable | Adult |
Others
NO
The aim of this study was to determine the effect of protein supplementation at breakfast and supper for 12 weeks beyond habitual intakes on lean body mass and bone mineral density in older adults.
Efficacy
The following measures would be conducted before and after 12 weeks of intervention.
1) Lean body mass and bone mineral density
1) bone metabolism markers
2) myokine
3) clock-gene
4) Physical functional parameter
5) physical activity(accelerometer)
6) morningness-eveningness type, the center for epidemiologic studies depression scale, pittsburgh sleep quality index (questionaire)
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
4
Prevention
Food |
Breakfast (0600 - 1000): intake of milk protein 10 g/day for 12 weeks
Supper (1800 - 2200): intake of milk protein 10 g/day for 12 weeks
Breakfast placebo (0600 - 1000)
Supper placebo (1800 - 2200)
65 | years-old | <= |
Not applicable |
Male and Female
1) Above 65 years older adults
2) Gives informed consent, agrees to be randomly assigned
1) Impaired cardiac (e.g., with cardiac pacemaker implants), kidney functions.
2) Physically active lifestyle
3) Intake of lipid and/or glucose lowering medication
4) Intake of Antipsychotics, Hypnotic, Steroids
5) Smoking habit
6) milk allergy
7) Phenylketonuria
8) Xylocaine allergy
9) Judged ineligible by a medical doctor.
10) History or presence of osteoporosis and compression fracture
11) Individuals with acute orthopedic pain and neurological symptom
12) Obesity (BMI>35kg/m2) and sleep apnea syndrome
13) High blood pressure (SBP:above140mmHg, and DBP:above 90mmHg)
100
1st name | |
Middle name | |
Last name | Shigenobu Shibata |
Waseda University
Faculty of Science and Engineering
2-2 Wakamatsu, Shinjuku, Tokyo
03-5369-7318
shibatas@waseda.jp
1st name | |
Middle name | |
Last name | Hyeon-Ki Kim |
Waseda University
Organization for University Research Initiatives
2-2 Wakamatsu, Shinjuku, Tokyo
03-5369-7318
hk.kim@aoni.waseda.jp
Waseda University
Meiji Co., Ltd
Profit organization
Meiji Co., Ltd, Tokyo Women's Medical University
NO
2017 | Year | 08 | Month | 10 | Day |
Unpublished
Completed
2017 | Year | 06 | Month | 27 | Day |
2017 | Year | 09 | Month | 10 | Day |
2017 | Year | 08 | Month | 09 | Day |
2019 | Year | 02 | Month | 12 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032737
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |